Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizo ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Nootropics are touted as “smart drugs” meant to improve cognitive performance. But there’s a lot we still don’t know about ...

The condition is most commonly diagnosed in people in their 70s, but you can take steps before then to make your brain more ...

Learn all about the best Delta 9 THC gummies that can help you relax and boost your sleep quality, while some featured ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to treat cardiovascular and kidney disease, and are being tested for Alzheimer’s ...

(NASDAQ:AXSM) released data from ACCORD-2, ADVANCE-2, and long-term safety trials AXS-05 (dextromethorphan-bupropion) in Alzheimer's ... agitation. The analyst notes that neuropsychiatry drugs ...

AXS-05 reduced Alzheimer’s severity and showed a 3. ... package for AXS-05 in Alzheimer's disease agitation. The analyst notes that neuropsychiatry drugs have been approved based on their ...

In August 2022, AXS-05 was approved in the USA for the treatment of depression under the trade name Auvelity and moving into Alzheimer’s agitation would be an important expansion. Chris Howerton, an ...

The US market looks expensive, so investors may be wondering which stocks to buy now against this backdrop. Regardless of where the markets are headed, investors may want to own companies that ...

The FDA approves an injectable Opdivo cancer drug; Axsome seeks approval for an Alzheimer's drug amid mixed results; Hain ...